Scinovex
articleTop 10% cited

A new rating scale for Alzheimer's disease

American Journal of Psychiatry · 1984 · Vol. 141(11) · pp. 1356–1364

Abstract

A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. Item descriptions, administration procedures, and scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28 normal elderly subjects were rated on 40 items. Twenty-one items with significant intraclass correlation coefficients for interrater reliability (range, .650-.989) and significant Spearman rank-order correlation coefficients for test-retest reliability (range, .514-1) constitute the final scale. Subjects with Alzheimer's disease had significantly more cognitive and noncognitive dysfunction than the normal elderly subjects.

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesLoginRating scaleBespokePsychologyDementiaDiseasePsychiatryMedicineComputer scienceDevelopmental psychology

MeSH terms

AgedAlzheimer DiseaseCognition DisordersFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesPsychometrics
Citations
4,157
FWCI
10.21
field-weighted impact
References
19
Percentile
99%
vs. same field & year
Citations per year
Cited by
Memantine for dementia
Cochrane Database of Systematic Reviews · 2006 · 1,019 citations
Cholinesterase inhibitors for Alzheimer's disease
Cochrane Database of Systematic Reviews · 2006 · 1,851 citations
Acetylcholinesterase inhibitors in Alzheimer’s disease
British Journal of Clinical Pharmacology · 1999 · 352 citations
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Neurology · 2009 · 2,470 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.